Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

Last month
Startups
Deals

Mer­ck ex­plores po­ten­tial of oral pep­tides in deal with Aus­tri­an biotech

Last month
Deals
R&D

Sid­dhartha Mukher­jee’s cell ther­a­py start­up nar­rows fo­cus as staff shrinks

Last month
R&D
Cell/Gene Tx

Trump phar­ma tar­iffs inch clos­er as ad­min­is­tra­tion con­firms US trade probe

Last month
R&D
Pharma

Bris­tol My­ers says Camzyos fails Phase 3 study in ge­net­ic heart con­di­tion

Last month
R&D
Pharma

CDC vac­cine ad­vi­sors are set to meet this week af­ter two-month de­lay and scruti­ny from Kennedy

Last month
R&D
Pharma

BioN­Tech-backed ADC mak­er Du­al­i­ty­Bio plans IPO on Hong Kong ex­change

Last month
Financing
Startups

Ab­b­Vie and San­doz agree to drop court spat over Rin­voq patents

Last month
Pharma
FDA+

AMA asks Unit­ed­Health Group to re­lax cy­ber­at­tack loan re­coup­ment

Last month
Health Tech

FDA's union read­ies ne­go­ti­a­tions with HHS over some fired staff

Last month
FDA+

San­doz sues Am­gen over nine-year launch de­lay for En­brel biosim­i­lar

Last month
Pharma
FDA+

What's Pfiz­er's next move af­ter shelv­ing its oral obe­si­ty drug danuglipron?

Last month
Deals
Pharma

Pri­mate re­searchers cope with un­cer­tain­ty as NIH ap­peals for pay­ment cuts in court 

Last month
R&D
Pharma

Third Har­mon­ic to shut­ter; Fu­ture Pak once again tar­gets Ther­at­e­ch­nolo­gies

Last month
News Briefing

Iron­wood to look for al­ter­na­tive paths af­ter FDA asks for an­oth­er Phase 3

Last month
Pharma
FDA+

Phar­ma tar­iffs to ar­rive 'in the next month or two,' com­merce sec­re­tary says

Last month
Pharma
Manufacturing

Verve un­veils ear­ly da­ta from sec­ond at­tempt at heart dis­ease gene edit­ing

Last month
R&D
Cell/Gene Tx

In a blow to its obe­si­ty pipeline, Pfiz­er drops oral drug af­ter liv­er in­jury case

Last month
R&D

Biotech’s sur­vival guide; What tar­iffs could mean for phar­ma; Con­gress push­es for $15B fed­er­al biotech in­vest­ment; ...

Last month
Weekly

Makary wants to re­place an­i­mal test­ing with organoids. It may take a while

Last month
R&D
FDA+

Bris­tol My­er­s' im­munother­a­py com­bo nets ap­provals in col­orec­tal and liv­er can­cer

Last month
R&D
FDA+

Re­cruiters say some bio­phar­mas pause hir­ing as they strug­gle to make sense of on­go­ing un­cer­tain­ty

Last month
People
Startups

Ar­genx’s Vyv­gart Hytru­lo sy­ringe is ap­proved in the US; Opthea to cut 65% of staff

Last month
News Briefing

CD­MOs an­tic­i­pate in­spec­tion bot­tle­necks af­ter mass FDA fir­ings

Last month
FDA+
Manufacturing
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times